Will Medicare cover Wegovy as soon as it’s approved for weight loss?
Medicare coverage for Wegovy (semaglutide 2.4 mg) depends on whether it is treated as a “covered benefit” under Medicare and whether a specific coverage path applies. Medicare generally does not automatically cover newer drugs for weight loss just because a manufacturer gets FDA approval; coverage can hinge on whether the drug is used within an approved indication and under Medicare’s rules for Part D (prescription drugs) formularies and prior authorization, or—less commonly—special coverage categories.
When does a Part D plan decide it will cover Wegovy?
Even if Medicare beneficiaries are eligible under Part D, coverage timing usually comes from plan adoption rather than a single nationwide start date. That means different Medicare Part D plans may add Wegovy at different times, often after negotiations and formulary updates. In practice, you can expect coverage to appear when:
- A plan’s formulary committee adds it (or makes it available under a “tier”), and
- Prior authorization criteria and step therapy rules are set (if applicable).
Could Medicare coverage depend on a specific national policy (NCD) or guidance?
For certain drugs or uses, Medicare may rely on national coverage determinations (NCDs) or local coverage determinations (LCDs) tied to medical criteria. If a national policy exists for semaglutide-based weight loss therapy, it can affect whether Medicare covers it broadly for the relevant indication. Without that type of policy, coverage often defaults to Part D formulary rules.
How can patients check whether Wegovy is covered right now?
A practical way to get an accurate answer is to check your specific Medicare Part D plan’s formulary:
- Look up “Wegovy” or “semaglutide 2.4 mg” in the plan formulary
- Review whether it requires prior authorization or documentation of BMI/weight-related comorbidities
- Confirm the expected out-of-pocket cost under your plan’s tier
If you share your plan name (or insurer), I can help you figure out what to look for in the formulary terms.
What if Medicare won’t cover Wegovy—what are the common workarounds?
If Wegovy is excluded or placed behind strict criteria, beneficiaries often face options like:
- Switching to a plan that covers it on-formulary
- Meeting the plan’s prior authorization requirements exactly
- Using an alternative medication option that is covered (if medically appropriate)
Is there a single “coverage start date” announced publicly?
There usually is not one universal date for Medicare coverage of a specific weight-loss drug; instead, coverage timing is driven by:
- FDA approval status for the intended indication, and
- Each Part D plan’s formulary and utilization-management decisions.
If you want, tell me whether you mean Medicare Part D (most common for Wegovy) or Medicare’s medical coverage via Part B for an in-office service, and your plan type (standalone Part D vs Medicare Advantage). That determines where the coverage decision actually happens.